Expression of Helicobacter pylori urease subunit B gene in Lactococcus lactis MG1363 and its use as a vaccine delivery system against H. pylori infection in mice

Vaccine

Volumn 19, Issue 28-29, 2001, Pages 3927-3935

  Lee, Ming Hsun ^a   Roussel, Yvonne ^a   Wilks, Mark ^a   Tabaqchali, Soad ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Helicobacter pylori vaccine; Infection; Lactococcus lactis

Indexed keywords

BACTERIAL VACCINE; HELICOBACTER PYLORI VACCINE; UREASE;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; EXPRESSION VECTOR; FEMALE; GENE EXPRESSION; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; IMMUNE RESPONSE; IMMUNIZATION; INFECTION PREVENTION; LACTOCOCCUS LACTIS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL VACCINES; BASE SEQUENCE; CLONING, MOLECULAR; FEMALE; GENE EXPRESSION; GENES, BACTERIAL; GENETIC VECTORS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN G; LACTOCOCCUS LACTIS; MICE; MICE, INBRED C57BL; PLASMIDS; PROTEIN SUBUNITS; UREASE; VACCINATION;

EID: 0035898938     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(01)00119-0     Document Type: Article

References (32)

1. Prospect for the development of a vaccine against Helicobacter pylori
2. Helicobacter pylori
3. Association of infection due to Helicobacter pylori with specific gastrointestinal pathology
4. Association between infection with Helicobacter pylori and risk of gastric cancer: Evidence from a prospective investigation
5. The response of cells from low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue to Helicobacter pylori
6. Vaccine against Helicobacter pylori: Fact or fiction?
7. Immunization against gastric Helicobacter infection in a mouse Helicobacter felis model
8. Rectal and intranasal immunisations with recombinant urease induce distinct local and serum immune responses in mice and protect against Helicobacter pylori infection
9. Protection against Helicobacter pylori infection in mice by intragastric vaccination with H. pylori antigens is achieved using a non-toxic mutant of E. coli heat-labile enterotoxin (LT) as adjuvant
10. Investigation of the structure and localisation of the ureases of Helicobacter pylori using monoclonal antibodies
11. Molecular cloning and expression of Campylobacter pylori species-specific antigens in Escherichia coli K-12
12. Immunisation of Balb/c mice against Helicobacter felis infection with Helicobacter pylori urease
13. Recombinant antigens prepared from the urease subunits of Helicobacter spp.: Evidence of protection in a mouse model of gastric infection
14. Oral administration with recombinant Helicobacter pylori urease induces secretory IgA antibodies and protect mice from challenge with Helicobacter felis
15. Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults
16. Protection of mice against gastric colonization by Helicobacter pylori by single oral dose immunization with attenuated Salmonella typhimurium producing urease subunits A and B
17. Mice are protected from Helicobacter pylori infection by nasal immunization with attenuated Salmonella typhimurium phoPc expressing urease A and B subunits
18. Safety and immunogenicity of phoP/phoQ-deleted Salmonella typhimurium expressing Helicobacter pylori urease in adult volunteers
19. On the safety of lactic acid bacteria
20. Genetic marking of Lactococcus lactis shows its survival in the human gastrointestinal tract
21. Study of gene transfer in vitro and in the digestive tract of gnotobiotic mice from Lactococcus lactis strains to various strains belonging to human intestinal flora
22. Enhanced secretory IgA and systemic IgG antibody responses after oral immunization with biodegradable microparticles containing antigen
23. Oral vaccination of mice against tetanus with recombinant Lactococcus lactis
24. High-frequency transformation, by electroporation, of Lactococcus lactis subsp. cremoris grown with glycine in osmotically stabilized media
25. Mucosal immunization with recombinant Lactococcus lactis
26. A standard mouse model of Helicobacter pylori infection: Introducing the Sydney strain
27. Factors affecting the immunogenicity of tetanus toxin fragment C expressed in Lactococcus lactis
28. Novel intranasal immunization techniques for antibody induction and protection of mice against gastric Helicobacter felis infection
29. Oral tolerance
30. Oral induction of the secretory antibody response by soluble or particulate antigens
31. Local and systemic tolerance to orally administered dinitrochlorobenzene is not broken by cholera toxin
32. Lactic acid bacteria as vaccine delivery vehicles